Skip to Content

International Isotopes Inc INIS

Morningstar Rating
$0.04 0.00 (7.89%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INIS is trading at a 39% discount.
Price
$0.04
Fair Value
$2.60
Uncertainty
Extreme
1-Star Price
$7.92
5-Star Price
$5.74
Economic Moat
Tzl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INIS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.04
Day Range
$0.040.04
52-Week Range
$0.020.10
Bid/Ask
$0.04 / $0.04
Market Cap
$21.32 Mil
Volume/Avg
104,500 / 81,952

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.69
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
40

Valuation

Metric
INIS
Price/Earnings (Normalized)
Price/Book Value
5.15
Price/Sales
1.69
Price/Cash Flow
Price/Earnings
INIS

Financial Strength

Metric
INIS
Quick Ratio
1.27
Current Ratio
1.76
Interest Coverage
−1.86
Quick Ratio
INIS

Profitability

Metric
INIS
Return on Assets (Normalized)
−2.49%
Return on Equity (Normalized)
−9.57%
Return on Invested Capital (Normalized)
−1.82%
Return on Assets
INIS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AGrkwshcdgPbwlx$70.0 Bil
MKKGY
Merck KGaA ADRGbjpbfsyrYtxfh$68.1 Bil
HLN
Haleon PLC ADRBdqqwfxYwg$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRXwzbnzqLggl$14.3 Bil
VTRS
Viatris IncGsrvzblhNbz$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRDdwstklyhFcf$11.9 Bil
CTLT
Catalent IncGfdtmkmcBbbmd$10.1 Bil
PRGO
Perrigo Co PLCBdjzpvvtqDfwxl$4.1 Bil
CURLF
Curaleaf Holdings IncTjhgnrlsySqnp$3.7 Bil
PBH
Prestige Consumer Healthcare IncJvqktcmJfrpslg$3.4 Bil

Sponsor Center